Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
14.58
-0.12 (-0.82%)
Dec 5, 2025, 4:00 PM EST - Market closed

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
1,015555523462596936
Upgrade
Market Cap Growth
58.50%6.22%13.23%-22.48%-36.35%22.51%
Upgrade
Enterprise Value
1,463740535464461758
Upgrade
Last Close Price
14.588.129.1311.2219.6733.22
Upgrade
PS Ratio
7.1510.05766.45---
Upgrade
PB Ratio
--2.19-7.18-6.178.254.82
Upgrade
P/TBV Ratio
----8.254.82
Upgrade
EV/Sales Ratio
9.9413.39785.10---
Upgrade
Debt / Equity Ratio
-1.38-2.19-6.13-2.761.270.25
Upgrade
Asset Turnover
0.470.140.00---
Upgrade
Inventory Turnover
5.583.61----
Upgrade
Quick Ratio
2.053.929.885.929.695.18
Upgrade
Current Ratio
2.234.2010.256.129.865.25
Upgrade
Return on Equity (ROE)
-----108.01%-61.14%
Upgrade
Return on Assets (ROA)
-42.54%-43.78%-36.14%-60.85%-34.85%-28.44%
Upgrade
Return on Capital (ROIC)
-54.18%-51.42%-41.41%-73.00%-41.51%-31.75%
Upgrade
Return on Capital Employed (ROCE)
-145.10%-94.80%-44.60%-124.40%-79.20%-52.50%
Upgrade
Earnings Yield
-27.04%-60.21%-38.57%-42.83%-24.16%-13.79%
Upgrade
FCF Yield
-22.19%-48.07%-26.63%-31.97%-24.98%-7.56%
Upgrade
Buyback Yield / Dilution
-20.89%-23.18%-31.11%-5.72%-11.36%-192.32%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.